Quezada earned an undergraduate degree in biochemistry from the P. Universidad Católica de Chile and a PhD from Dartmouth Medical School, where his research focused on the mechanisms for the induction of transplantation tolerance. Working with Dr Randy Noelle at Dartmouth, Dr Quezada developed a model to study anti-CD154 graft tolerance and made several fundamental contributions to the understanding of the immune regulation and mechanisms of transplantation rejection and tolerance. In 2004, Dr Quezada joined the laboratory of Dr James Allison at Memorial Sloan-Kettering Cancer Center, where he has carried out postdoctoral research aimed at understanding the mechanisms governing anti-tumour T-cell immunity and how these mechanisms can be manipulated for the generation of potent anti-tumour immune responses. Quezada earned an undergraduate degree in biochemistry from the P. Universidad Católica de Chile and a PhD from Dartmouth Medical School, where his research focused on the mechanisms for the induction of transplantation tolerance. Working with Dr Randy Noelle at Dartmouth, Dr Quezada developed a model to study anti-CD154 graft tolerance and made several fundamental contributions to the understanding of the immune regulation and mechanisms of transplantation rejection and tolerance. In 2004, Dr Quezada joined the laboratory of Dr James Allison at Memorial Sloan-Kettering Cancer Center, where he has carried out postdoctoral research aimed at understanding the mechanisms governing anti-tumour T-cell immunity and how these mechanisms can be manipulated for the generation of potent anti-tumour immune responses.

fermentation